FLYNN JAMES E

PrivateCIK: 1352546
Location

NEW YORK, NY

InsiderFLYNN JAMES ECIK 1352546
IssuerACUTUS MEDICAL, INC.CIK 1522860
Director10% OwnerOther
Since Aug 2020
-4.21M
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
5
Total transactions
4.21M disposed
Non-Derivative Transactions0
No non-derivative transactions reported
Derivative Transactions5

Warrant to Purchase Common Stock

Indirect
D · Disposition
Converts to

Class A Common Stock

1.89M shares

Shares

1.89M

Strike price

1.1114

Held after

0.00

Exercisable

1/27/2025

Warrant to Purchase Common Stock

Indirect
D · Disposition
Converts to

Class A Common Stock

1.89M shares

Shares

1.89M

Strike price

1.1114

Held after

0.00

Exercisable

1/27/2025

Warrant to Purchase Common Stock

Indirect
D · Disposition
Converts to

Class A Common Stock

210K shares

Shares

210K

Strike price

16.67

Held after

0.00

Exercisable

1/27/2025

Warrant to Purchase Common Stock

Indirect
D · Disposition
Converts to

Class A Common Stock

193K shares

Shares

193K

Strike price

0.097

Held after

0.00

Exercisable

1/27/2025

Warrant to Purchase Common Stock

Indirect
D · Disposition
Converts to

Class A Common Stock

31.12K shares

Shares

31.12K

Strike price

0.097

Held after

0.00

Exercisable

1/27/2025
Non-Derivative Holdings (Post-Transaction)3

Common Stock

Indirect
Shares owned1.03M

Common Stock

Indirect
Shares owned20.82K

Common Stock

Indirect
Shares owned1.62M
Total
2.67M indirect2.67M
Derivative Holdings (Post-Transaction)2

Series A Common Stock Equivalent Convertible Preferred Stock

Indirect
Underlying security
Class A Common Stock

Underlying shares

948.39K

Shares owned

948.39K

Exercise price

Expiration

Exercise window

Series A Common Stock Equivalent Convertible Preferred Stock

Indirect
Underlying security
Class A Common Stock

Underlying shares

1.82M

Shares owned

1.82M

Exercise price

Expiration

Exercise window

Total

Underlying

2.76M

Owned

2.76M

FLYNN JAMES E — Insider Transaction (Form 4) Filed Jan 28, 2025 | Finecho